Zimmer Biomet Holdings, Inc. (ZBH) DCF Valuation

Zimmer Biomet Holdings, Inc. (ZBH) DCF Valuation

US | Healthcare | Medical - Devices | NYSE
Zimmer Biomet Holdings, Inc. (ZBH) DCF Valuation

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Zimmer Biomet Holdings, Inc. (ZBH) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

If you’re an investor or analyst, this [ZBH] DCF Calculator is the perfect tool for accurate valuation. Equipped with real data from Zimmer Biomet Holdings, Inc., you can adjust forecasts and immediately observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 7,024.5 6,827.3 6,939.9 7,394.2 7,678.6 7,855.9 8,037.2 8,222.8 8,412.6 8,606.8
Revenue Growth, % 0 -2.81 1.65 6.55 3.85 2.31 2.31 2.31 2.31 2.31
EBITDA 969.7 2,160.1 2,212.6 2,214.3 2,250.9 2,146.0 2,195.6 2,246.2 2,298.1 2,351.1
EBITDA, % 13.8 31.64 31.88 29.95 29.31 27.32 27.32 27.32 27.32 27.32
Depreciation 1,032.7 937.7 926.4 951.7 965.2 1,056.2 1,080.6 1,105.6 1,131.1 1,157.2
Depreciation, % 14.7 13.73 13.35 12.87 12.57 13.45 13.45 13.45 13.45 13.45
EBIT -63.0 1,222.4 1,286.2 1,262.6 1,285.7 1,089.8 1,114.9 1,140.7 1,167.0 1,193.9
EBIT, % -0.89686 17.9 18.53 17.08 16.74 13.87 13.87 13.87 13.87 13.87
Total Cash 802.1 378.1 375.7 415.8 525.5 547.4 560.0 572.9 586.1 599.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1,452.7 1,259.6 1,381.5 1,442.4 1,480.7
Account Receivables, % 20.68 18.45 19.91 19.51 19.28
Inventories 2,450.7 2,148.0 2,147.2 2,385.2 2,235.3 2,492.8 2,550.3 2,609.2 2,669.5 2,731.1
Inventories, % 34.89 31.46 30.94 32.26 29.11 31.73 31.73 31.73 31.73 31.73
Accounts Payable 330.0 306.5 354.1 410.6 194.6 351.6 359.7 368.0 376.5 385.2
Accounts Payable, % 4.7 4.49 5.1 5.55 2.53 4.48 4.48 4.48 4.48 4.48
Capital Expenditure -117.9 -152.0 -187.9 -602.8 -356.8 -305.0 -312.0 -319.2 -326.6 -334.1
Capital Expenditure, % -1.68 -2.23 -2.71 -8.15 -4.65 -3.88 -3.88 -3.88 -3.88 -3.88
Tax Rate, % 12.81 12.81 12.81 12.81 12.81 12.81 12.81 12.81 12.81 12.81
EBITAT -31.5 983.8 737.6 1,211.4 1,121.0 808.7 827.4 846.5 866.0 886.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2,690.1 2,241.8 1,402.6 1,317.9 1,625.0 1,403.1 1,511.0 1,545.9 1,581.6 1,618.1
WACC, % 6.75 7.04 6.82 7.19 7.1 6.98 6.98 6.98 6.98 6.98
PV UFCF
SUM PV UFCF 6,256.9
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 1,683
Terminal Value 56,489
Present Terminal Value 40,315
Enterprise Value 46,572
Net Debt 5,679
Equity Value 40,893
Diluted Shares Outstanding, MM 204
Equity Value Per Share 200.56

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator with pre-filled real ZBH financials.
  • Real-World Data: Historical data and forward-looking estimates (as shown in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Zimmer Biomet's valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, accompanied by step-by-step instructions.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Zimmer Biomet Holdings, Inc. (ZBH).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs for precise calculations.
  • Customizable Forecast Assumptions: Easily alter growth rates, capital expenditures, and discount rates to fit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Zimmer Biomet Holdings, Inc. (ZBH).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.

How It Works

  • Step 1: Download the prebuilt Excel template containing Zimmer Biomet's data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view the updated results, including Zimmer Biomet's intrinsic value.
  • Step 5: Utilize the outputs to make informed investment decisions or create reports.

Why Choose This Calculator for Zimmer Biomet Holdings, Inc. (ZBH)?

  • Designed for Industry Experts: A sophisticated tool tailored for healthcare analysts, financial officers, and consultants.
  • Accurate Financial Data: Zimmer Biomet’s historical and projected financials are preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly Interface: Step-by-step guidance ensures a smooth experience throughout the calculation process.

Who Should Use This Product?

  • Investors: Accurately assess Zimmer Biomet's fair value before making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to ZBH.
  • Consultants: Easily customize the template for valuation reports tailored to clients interested in Zimmer Biomet.
  • Entrepreneurs: Acquire insights into financial modeling techniques employed by leading healthcare companies.
  • Educators: Implement it as a teaching resource to illustrate valuation methodologies in finance courses.

What the Template Contains

  • Historical Data: Includes Zimmer Biomet's past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Zimmer Biomet's intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Zimmer Biomet's financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.